Dimension Inx is an emerging leader in biofabrication, the next frontier in medicine. Our 3D-Painting Materials Design and Manufacturing System offers the versatility, manufacturability, and affordability necessary for widespread adoption of tissue-engineered regenerative medical products. We are creating biomaterials and 3D-printed implants that fundamentally change how we treat human disease and debilitation.

We are developing a new class of treatments that dramatically improves the standard of care and addresses the shortage of donor tissues and organs. Our team brings expertise in materials science and tissue engineering to partner with the world’s best clinicians and surgeons and forward-thinking medical products companies to deliver new medical solutions to patients.


Caralynn Nowinski Collens

Co-founder / CEO

Founder, CEO, Board Director, Innovator. Passionate about building teams and organizations that leverage technology to drive transformational change and improve quality of life. Recognized for deploying innovative business models and building strategic partnerships to accelerate new product development. Trusted advisor to corporate executives, entrepreneurs, university leaders, and government on innovation strategy. Track record for translating vision into results that matter and delivering economic returns.

Ramille Shah

Co-founder / CSO

Prof. Ramille Shah is an Associate Professor in the Department of Bioengineering at the University of Illinois at Chicago (UIC) and the co-Founder and Chief Scientific Officer of Dimension Inx, LLC. She has over 20 years experience in the biomaterials and tissue engineering fields and in the last 10 years has established herself as a renowned leader in materials development for 3D-printing. Her work relating to everything from ovary organ and musculoskeletal tissue biofabrication to new methods for printing metals, and Martian and lunar dust has led to over a dozen issued and pending patents, high impact publications, and has been featured in Forbes Magazine, Crain’s Chicago Business Magazine (also named Crain’s 40 Under 40), Fox 32 News, National Public Radio, the National Science Foundation’s Science Nation News, and other national and international media outlets. Prof. Shah co-founded Dimension Inx, LLC to facilitate the translation and commercialization of the 3D-printable material technologies developed in her lab. As Chief Scientific Officer of Dimension Inx, Prof. Shah leads the regulatory and product development strategy, and supports the research, innovation, and quality management activities at Dimension Inx. Prof. Shah earned her B.S. in Materials Science and Engineering (MSE) at Northwestern University and her Ph.D. in MSE with a specialty in Biomaterials from the Massachusetts Institute of Technology.

Adam E. Jakus

Co-founder / CTO

A Ph.D Materials Scientist and Engineer with diverse and extensive research and development experience in the fields of 3D-Printing Material Design and Development, Tissue Engineering, Metallurgy, and Medicine. I have spent the last four years developing, characterizing, and applying new 3D-printable material systems derived from everything from biological extra cellular matrix and living cells to metals, functional ceramics, and graphene with applications ranging from the fields of tissue engineering and reproductive medicine to energy systems and aerospace. I give particular attention to the scale-up potential and ease of translation of the material systems and methods. I have extensive experience working hand-in-hand with materials scientists in traditional fields, as well as with practicing medical clinicians and surgeons in fields including but not limited to obstetrics and gynecology, plastic surgery, orthopedic surgery, pediatric surgery, and organ transplant surgery. Extensive research and development experience is supplemented with experience in intellectual property creation and strategy, management and business training, as well as classroom and laboratory teaching and mentoring.